Spyre Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 151-175 of 781 matching filings.

Per page
25
Current page
7
SC 13G/A File 005-89456

SC 13G/A filing

Filing date
10 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
16 May 2024
Reporting date
14 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-278810

424B3

Filing date
15 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-278810

EFFECT filing

Filing date
29 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
25 Apr 2024
Reporting date
25 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89456

SC 13D/A

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-278810

UPLOAD filing

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89456

SPYRE THERAPEUTICS INC.

Filing date
23 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-37722

ARS

Filing date
02 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER File 333-276251

SEC STAFF LETTER filing

Filing date
02 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-273769

EFFECT filing

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-276251

EFFECT filing

Filing date
01 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37722

DEF 14A

Filing date
01 Apr 2024
Reporting date
13 May 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .